Personalis Inc (PSNL)

8.26 +0.61  +7.97% NASDAQ Apr 6, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
08/13/2020 17:00 EDT Misc Personalis Inc Second Quarter Earnings Conference Call in 2020
05/15/2020 Earnings Personalis Inc First Quarter Earnings Results in 2020
03/25/2020 17:00 EDT Misc Personalis Inc Fourth Quarter Earnings Conference Call for 2019
03/25/2020 Earnings Personalis Inc Fourth Quarter Earnings for 2019 Release
03/25/2020 Misc Personalis Inc Annual Report for 2019
11/13/2019 08:00 EST Misc Personalis Inc Third Quarter Earnings Conference Call for 2019
11/13/2019 Earnings Personalis Inc Third Quarter Earnings for 2019 Release
08/13/2019 17:00 EDT Misc Personalis Inc Second Quarter Earnings Conference Call in 2019
08/13/2019 Earnings Personalis Inc Second Quarter Earnings in 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.personalis.com
  • Investor Relations URL: N/A
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: May. 15, 2020
  • Last Earnings Release: Mar. 25, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services.

Top Fund Holders

Symbol Name Weighting
ARKG ARK Genomic Revolution ETF 1.29%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.